171 related articles for article (PubMed ID: 34298413)
1. Impact of α-modifications on the activity of triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Fairweather AER; Goetz DB; Schroeder CM; Bhuiyan NH; Varney ML; Wiemer DF; Holstein SA
Bioorg Med Chem; 2021 Aug; 44():116307. PubMed ID: 34298413
[TBL] [Abstract][Full Text] [Related]
2. α-Methylation enhances the potency of isoprenoid triazole bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Matthiesen RA; Varney ML; Xu PC; Rier AS; Wiemer DF; Holstein SA
Bioorg Med Chem; 2018 Jan; 26(2):376-385. PubMed ID: 29248353
[TBL] [Abstract][Full Text] [Related]
3. Amides as bioisosteres of triazole-based geranylgeranyl diphosphate synthase inhibitors.
Goetz DB; Varney ML; Wiemer DF; Holstein SA
Bioorg Med Chem; 2020 Aug; 28(16):115604. PubMed ID: 32690260
[TBL] [Abstract][Full Text] [Related]
4. Bishomoisoprenoid triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.
Wills VS; Metzger JI; Allen C; Varney ML; Wiemer DF; Holstein SA
Bioorg Med Chem; 2017 Apr; 25(8):2437-2444. PubMed ID: 28302510
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Evaluation of Isoprenoid Triazole Bisphosphonate Inhibitors of Geranylgeranyl Diphosphate Synthase: Impact of Olefin Stereochemistry on Toxicity and Biodistribution.
Haney SL; Chhonker YS; Varney ML; Talmon G; Smith LM; Murry DJ; Holstein SA
J Pharmacol Exp Ther; 2019 Nov; 371(2):327-338. PubMed ID: 31420526
[TBL] [Abstract][Full Text] [Related]
6. α-Amino bisphosphonate triazoles serve as GGDPS inhibitors.
Gehrke NR; Feng D; Ayub Ali M; Maalouf MA; Holstein SA; Wiemer DF
Bioorg Med Chem Lett; 2024 Apr; 102():129659. PubMed ID: 38373465
[TBL] [Abstract][Full Text] [Related]
7. Olefin Isomers of a Triazole Bisphosphonate Synergistically Inhibit Geranylgeranyl Diphosphate Synthase.
Allen C; Kortagere S; Tong H; Matthiesen RA; Metzger JI; Wiemer DF; Holstein SA
Mol Pharmacol; 2017 Mar; 91(3):229-236. PubMed ID: 28057800
[TBL] [Abstract][Full Text] [Related]
8. Geranyl and neryl triazole bisphosphonates as inhibitors of geranylgeranyl diphosphate synthase.
Zhou X; Ferree SD; Wills VS; Born EJ; Tong H; Wiemer DF; Holstein SA
Bioorg Med Chem; 2014 May; 22(9):2791-8. PubMed ID: 24726306
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of a series of aromatic bisphosphonates.
Barney RJ; Wasko BM; Dudakovic A; Hohl RJ; Wiemer DF
Bioorg Med Chem; 2010 Oct; 18(20):7212-20. PubMed ID: 20832326
[TBL] [Abstract][Full Text] [Related]
10. ω-Hydroxy isoprenoid bisphosphonates as linkable GGDPS inhibitors.
Bhuiyan NH; Varney ML; Bhattacharya DS; Payne WM; Mohs AM; Holstein SA; Wiemer DF
Bioorg Med Chem Lett; 2019 Oct; 29(19):126633. PubMed ID: 31474482
[TBL] [Abstract][Full Text] [Related]
11. Stereoselective Synthesis of Homoneryl and Homogeranyl Triazole Bisphosphonates.
Matthiesen RA; Wills VS; Metzger JI; Holstein SA; Wiemer DF
J Org Chem; 2016 Oct; 81(19):9438-9442. PubMed ID: 27648672
[TBL] [Abstract][Full Text] [Related]
12. Recent Advances in the Development of Mammalian Geranylgeranyl Diphosphate Synthase Inhibitors.
Haney SL; Wills VS; Wiemer DF; Holstein SA
Molecules; 2017 May; 22(6):. PubMed ID: 28555000
[TBL] [Abstract][Full Text] [Related]
13. A new motif for inhibitors of geranylgeranyl diphosphate synthase.
Foust BJ; Allen C; Holstein SA; Wiemer DF
Bioorg Med Chem; 2016 Aug; 24(16):3734-41. PubMed ID: 27338660
[TBL] [Abstract][Full Text] [Related]
14. In vitro studies in a myelogenous leukemia cell line suggest an organized binding of geranylgeranyl diphosphate synthase inhibitors.
Reilly JE; Zhou X; Tong H; Kuder CH; Wiemer DF; Hohl RJ
Biochem Pharmacol; 2015 Jul; 96(2):83-92. PubMed ID: 25952057
[TBL] [Abstract][Full Text] [Related]
15. Nonbisphosphonate inhibitors of Plasmodium falciparum FPPS/GGPPS.
Kabeche S; Aida J; Akther T; Ichikawa T; Ochida A; Pulkoski-Gross MJ; Smith M; Humphries PS; Yeh E
Bioorg Med Chem Lett; 2021 Jun; 41():127978. PubMed ID: 33766764
[TBL] [Abstract][Full Text] [Related]
16. Mono- and dialkyl isoprenoid bisphosphonates as geranylgeranyl diphosphate synthase inhibitors.
Wiemer AJ; Yu JS; Lamb KM; Hohl RJ; Wiemer DF
Bioorg Med Chem; 2008 Jan; 16(1):390-9. PubMed ID: 17905588
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of geranylgeranyl diphosphate synthase by bisphosphonates: a crystallographic and computational investigation.
K-M Chen C; Hudock MP; Zhang Y; Guo RT; Cao R; No JH; Liang PH; Ko TP; Chang TH; Chang SC; Song Y; Axelson J; Kumar A; Wang AH; Oldfield E
J Med Chem; 2008 Sep; 51(18):5594-607. PubMed ID: 18800762
[TBL] [Abstract][Full Text] [Related]
18. Bisphosphonates induce autophagy by depleting geranylgeranyl diphosphate.
Wasko BM; Dudakovic A; Hohl RJ
J Pharmacol Exp Ther; 2011 May; 337(2):540-6. PubMed ID: 21335425
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and preliminary anticancer evaluation of new triazole bisphosphonate-based isoprenoid biosynthesis inhibitors.
Legigan T; Migianu-Griffoni E; Redouane MA; Descamps A; Deschamp J; Gager O; Monteil M; Barbault F; Lecouvey M
Eur J Med Chem; 2021 Mar; 214():113241. PubMed ID: 33571830
[TBL] [Abstract][Full Text] [Related]
20. Triazole-based inhibitors of geranylgeranyltransferase II.
Zhou X; Hartman SV; Born EJ; Smits JP; Holstein SA; Wiemer DF
Bioorg Med Chem Lett; 2013 Feb; 23(3):764-6. PubMed ID: 23266123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
